Bank of Montreal’s Revolution Medicines RVMD Stock Holding History

Bank of Montreal’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.26M	Buy	23,262 +20,514	+747%	+$2.07M	﹤0.01%	1612
2025 Q4	$219K	Buy	+2,748	New	+$180K	﹤0.01%	2796
2024 Q2	–	Sell	-27,904	Closed	-$903K	–	4188
2024 Q1	$903K	Buy	+27,904	New	+$827K	﹤0.01%	2064
2022 Q4	–	Sell	-104	Closed	-$2	–	4241
2022 Q3	$2	Sell	104 -87,949	-100%	-$1.93M	﹤0.01%	3991
2022 Q2	$1.68K	Buy	+88,053	New	+$1.71M	﹤0.01%	1989
2021 Q2	–	Sell	-1,593	Closed	-$72K	–	4718
2021 Q1	$72K	Sell	1,593 -4,426	-74%	-$198K	﹤0.01%	3549
2020 Q4	$232K	Buy	6,019 +4,177	+227%	+$165K	﹤0.01%	3150
2020 Q3	$73K	Buy	1,842 +625	+51%	+$17.3K	﹤0.01%	3254
2020 Q2	$33K	Buy	+1,217	New	+$38.3K	﹤0.01%	3624

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of Montreal's RVMD Position: Q1 2026 in Review

Bank of Montreal increased its Revolution Medicines (RVMD) stake by 747% in Q1 2026, buying an estimated $2.07M and bringing the position to 23,262 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Bank of Montreal first reported a position in RVMD in Q2 2020 and has held it in 9 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Bank of Montreal held 23,262 shares of Revolution Medicines worth $2.26M as of Q1 2026.
Bank of Montreal bought 20,514 Revolution Medicines shares in Q1 2026, an estimated $2.07M.
Revolution Medicines made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1612 holding.
Bank of Montreal first reported a position in Revolution Medicines in Q2 2020 and has held it in 9 quarters since.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.